Foamix Pharmaceuticals (NASDAQ:FOMX) Cut to “Sell” at Zacks Investment Research – Riverton Roll
Foamix Pharmaceuticals (NASDAQ:FOMX) Cut to “Sell” at Zacks Investment Research Riverton Roll
Zacks Investment Research downgraded shares of Foamix Pharmaceuticals (NASDAQ:FOMX) from a hold rating to a sell rating in a report released on Thursday …
Source: Investment New Feed